Free Trial
NASDAQ:SRNE

Sorrento Therapeutics (SRNE) Stock Price, News & Analysis

Sorrento Therapeutics logo
$0.0013 0.00 (-7.14%)
As of 07/3/2025 12:54 PM Eastern

About Sorrento Therapeutics Stock (NASDAQ:SRNE)

Key Stats

Today's Range
$0.0013
$0.0020
50-Day Range
N/A
52-Week Range
$0.00
$0.02
Volume
593,018 shs
Average Volume
92,362 shs
Market Capitalization
$716.66 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sorrento Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

SRNE MarketRank™: 

Sorrento Therapeutics scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Sorrento Therapeutics.

    • Percentage of Shares Shorted

      0.66% of the float of Sorrento Therapeutics has been sold short.
    • Short Interest Ratio / Days to Cover

      Sorrento Therapeutics has a short interest ratio ("days to cover") of 27, which indicates bearish sentiment.
    • Change versus previous month

      Short interest in Sorrento Therapeutics has recently decreased by 0.01%, indicating that investor sentiment is improving.
    • Dividend Yield

      Sorrento Therapeutics does not currently pay a dividend.

    • Dividend Growth

      Sorrento Therapeutics does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      0.66% of the float of Sorrento Therapeutics has been sold short.
    • Short Interest Ratio / Days to Cover

      Sorrento Therapeutics has a short interest ratio ("days to cover") of 27, which indicates bearish sentiment.
    • Change versus previous month

      Short interest in Sorrento Therapeutics has recently decreased by 0.01%, indicating that investor sentiment is improving.
    • News Coverage This Week

      MarketBeat has tracked 2 news articles for Sorrento Therapeutics this week, compared to 0 articles on an average week.
    • Search Interest

      Only 2 people have searched for SRNE on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
    • MarketBeat Follows

      Only 1 people have added Sorrento Therapeutics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Sorrento Therapeutics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 2.60% of the stock of Sorrento Therapeutics is held by insiders.

    • Percentage Held by Institutions

      Only 0.02% of the stock of Sorrento Therapeutics is held by institutions.

    • Read more about Sorrento Therapeutics' insider trading history.
    Receive SRNE Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    SRNE Stock News Headlines

    Sorrento Therapeutics Inc (SRNE) - Investing.com
    SRNE Sorrento Therapeutics, Inc. - Seeking Alpha
    The End of Elon Musk…?
    The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
    Sorrento Therapeutics Inc (SRNE)
    Sorrento Therapeutics Inc SRNE
    See More Headlines

    SRNE Stock Analysis - Frequently Asked Questions

    Sorrento Therapeutics' stock was trading at $0.0005 at the beginning of 2025. Since then, SRNE stock has increased by 160.0% and is now trading at $0.0013.

    Shares of SRNE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Sorrento Therapeutics investors own include NIO (NIO), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Gilead Sciences (GILD), Advanced Micro Devices (AMD) and Johnson & Johnson (JNJ).

    Company Calendar

    Today
    7/04/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Biological products, except diagnostic
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:SRNE
    Employees
    800
    Year Founded
    2006

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $60.32 million
    Price / Cash Flow
    N/A
    Price / Book
    N/A

    Miscellaneous

    Free Float
    536,948,000
    Market Cap
    $716.66 thousand
    Optionable
    No Data
    Beta
    0.97

    Social Links

    5G Stocks: The Path Forward is Profitable Cover

    Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

    Get This Free Report

    This page (NASDAQ:SRNE) was last updated on 7/4/2025 by MarketBeat.com Staff
    From Our Partners